ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5427.63M
Enterprise Value 3266.77M
Trailing P/E 23.69
Forward P/E 125.50
PEG Ratio (5 yr expected) 12.45
Price/Sales (ttm)4.05
Price/Book (mrq)1.62
Enterprise Value/Revenue 32.53
Enterprise Value/EBITDA 67.88

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 17.74%
Operating Margin (ttm)26.48%

Management Effectiveness

Return on Assets (ttm)6.22%
Return on Equity (ttm)7.10%

Income Statement

Revenue (ttm)105.56M
Revenue Per Share (ttm)7.31
Quarterly Revenue Growth (yoy)-8.30%
Gross Profit (ttm)74.28M
EBITDA 33.86M
Net Income Avi to Common (ttm)18.72M
Diluted EPS (ttm)1.27
Quarterly Earnings Growth (yoy)-4.30%

Balance Sheet

Total Cash (mrq)159.01M
Total Cash Per Share (mrq)11.19
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)17.98
Book Value Per Share (mrq)18.55

Cash Flow Statement

Operating Cash Flow (ttm)34.92M
Levered Free Cash Flow (ttm)33.13M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.41
52-Week Change 3-43.48%
S&P500 52-Week Change 34.04%
52 Week High 353.08
52 Week Low 328.54
50-Day Moving Average 335.29
200-Day Moving Average 336.58

Share Statistics

Avg Vol (3 month) 3172.94k
Avg Vol (10 day) 3363.83k
Shares Outstanding 514.21M
Float 13.66M
% Held by Insiders 13.86%
% Held by Institutions 191.74%
Shares Short (Feb 28, 2019) 42.26M
Short Ratio (Feb 28, 2019) 417.36
Short % of Float (Feb 28, 2019) 422.37%
Short % of Shares Outstanding (Feb 28, 2019) 415.92%
Shares Short (prior month Jan 31, 2019) 42.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A